Lasso (lassoplatform.io), the world’s first and only omnichannel platform for healthcare marketing and analytics, announced the launch of its new endemic Publisher Suite to continue its mission of becoming a true end-to-end operating system. This exciting initiative is being led by Eric Shih, Lasso’s Chief Growth Officer, who previously built one of the world’s largest premium publisher marketplaces at Teads. Lasso’s platform now powers a streamlined media buying and selling workflow for both marketers and publishers alike.
Also Read: RayCare in Clinical use with CyberKnife at Swiss Medical Network in Switzerland
Since 2019, Lasso has been a pioneer and leader in providing end-to-end platform solutions for healthcare marketers, and this new business expansion will extend these same capabilities to endemic healthcare publishers. The Publisher Suite provides a singular dashboard with seamless access to each module of the selling journey:
- Monetization: Comprehensive ad serving and programmatic tools for publisher direct sales and monetization through Lasso’s endemic advertising marketplace, connecting HCP and DTC marketers directly with endemic publisher audiences.
- Extension: Plan and activate audience and reach extension campaigns by leveraging Lasso Blueprint, the most advanced, self-service audience builder for healthcare.
- Measurement: Understand the end-to-end, real-world performance of campaigns with built-in Rx lift and audience quality analytics.
Given its deep partnerships with healthcare marketers, Lasso is well-positioned to rapidly scale its endemic ad marketplace. This platform is already connecting leading agencies such as Klick Health, Good Apple, and Fingerpaint, who are bringing high-value demand, to prominent healthcare publishers such as GoodRx, Haymarket Media, HMP Global, The Doctor’s Channel, Global RPH, and many others. For marketers, Lasso’s platform is now the industry’s ultimate one-stop shop, offering complete control and a harmonious experience for both endemic and non-endemic campaigns.
In March, Lasso partnered with a top pharma agency and a leading prescription drug information website used by thousands of physicians and millions of Americans each month. By leveraging Lasso’s advanced identity resolution, the endemic publisher was able to distinguish high-value HCP (Healthcare Provider) audiences from consumers and, hence, monetize those segments at a premium CPM and drive incremental revenue. The agency’s goal was to open up an avenue to reach HCPs that are inaccessible through traditional programmatic channels and increase media engagement. By participating in Lasso’s new endemic marketplace, the agency was able to deliver the campaign in full and renew with the drug brand for additional flights. Within the first month, the campaign achieved a 2.2% incremental reach of elusive HCPs beyond the open web and a 30% increase in CTR on just one endemic website. These results are remarkable as endemic sites tend to be stickier and more contextually relevant for both physicians and patients who use them, leading to higher brand recall and more desired behaviors such as prescription fills, over-the-counter sales, etc.